Kyushu University Academic Staff Educational and Research Activities Database
Researcher information (To researchers) Need Help? How to update
Kentaro TANAKA Last modified date:2023.06.29

Associate Professor / Internal Medicine
Department of Clinical Medicine
Faculty of Medical Sciences

Graduate School
Undergraduate School
Other Organization
Administration Post

E-Mail *Since the e-mail address is not displayed in Internet Explorer, please use another web browser:Google Chrome, safari.
 Reseacher Profiling Tool Kyushu University Pure
Academic Degree
Country of degree conferring institution (Overseas)
Field of Specialization
Medical Oncology, Respiratory Medicine, Immunology
Total Priod of education and research career in the foreign country
Research Interests
  • Role of MAPK signaling in regulatory mechanisms of immune checkpoint molecules.
    keyword : MAP kinase, immune checkpoint molecule, IL-1beta, IFN-gamma
  • Development of novel immunotherapies to overcome resistance to immune checkpoint inhibitors.
    keyword : advanced non-small cell lung cancer, resistance, immunotherapy
  • Function of Hippo pathways in non-small cell lung cancer
    keyword : Hippo pathway, non-small cell lung cancer
  • Development of biomarkers in the treatment of immune checkpoint inhibitors
    keyword : biomarker, immune checkpoint inhibitor, T lymphocyte, metabolite
  • basic research and development of new treatment in small-cell lung cancer
    keyword : advanced small cell lung cancer, clinical trials
  • Regulation of immune system in tumor cells by cytokines in the tumor microenvironment
    keyword : tumor cells, immune checkpoint, tumor microenvironment, cytokine, macrophage
  • Clinical development of novel treatment for advanced EGFR-mutation positive non-small cell lung cancer
    keyword : lung cancer, novel treatment, clinical trials
Academic Activities
1. Asahina H, Tanaka K, Morita S, Maemondo M, Seike M, Okamoto I, Oizumi S, Kagamu H, Takahashi K, Kikuchi T, Isobe T, Sugio K, Kobayashi K, A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non-Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)
, Clinical Lung Cancer, 2021.03.
2. Ando N, Tanaka K, Otsubo K, Toyokawa G, Ikematsu Y, Ide M, Yoneshima Y, Iwama E, Inoue H, Ijichi K, Tagawa T, Nakanishi Y, Okamoto I, Association of MOB1 Expression with Poor Disease-Free Survival in Individuals with Non–Small Cell Lung Cancer, Thoracic Cancer, 2020.11.
3. Ikematsu Y, Tanaka K, Toyokawa G, Ijichi K, Ando N, Yoneshima Y, Iwama E, Inoue H, Tagawa T, Nakanishi Y, Okamoto I, NEUROD1 is highly expressed in extensive-stage small cell lung cancer and promotes tumor cell migration., Lung Cancer , 2020.08.
4. Yanagihara T, Tanaka K, Matsumoto K, A measuring method for occupancy of immune checkpoint inhibitors in the cell surface, Biochemical and Biophysical Research Communications, 2020.06.
1. Kentaro TANAKA, 「Next-generation TKI」, World Conference on Lung Cancer, 2018.10.
Other Educational Activities
  • 2018.08.